VANGUARD GROUP INC 13D/13G Filings for Niagen Bioscience Inc (NAGE)

VANGUARD GROUP INC 13D and 13G filings for Niagen Bioscience Inc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-31
11:03 am
Purchase
2025-09-3013GNiagen Bioscience Inc
NAGE
VANGUARD GROUP INC4,021,650
5.040%
4,021,650increase
(New Position)
Filing